Form 4: Tyra Biosciences CEO Acquires Shares Through Employee Stock Purchase Plan
SEC Form 4 Filing
Todd Harris, President and CEO of Tyra Biosciences, acquired 1,880 shares of common stock through the company's Employee Stock Purchase Plan on March 15, 2024.
Summary
- On March 15, 2024, Todd Harris, the President and CEO of Tyra Biosciences, acquired 1,880 shares of common stock.
- The acquisition was made through the Issuer's 2021 Employee Stock Purchase Plan.
- The price per share was $6.579.
- Following the transaction, Harris directly owns 1,504,577 shares of Tyra Biosciences common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The CEO's participation in the employee stock purchase plan suggests confidence in the company, but the transaction itself is routine.
Positives
- The CEO's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.
Industry Context
This filing is a routine disclosure related to insider transactions and is a common occurrence for publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a small purchase of shares by the CEO.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of transaction: Todd Harris acquired 1,880 shares of common stock. |
| 03/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.